Royce & Associates’s Axonics, Inc. Common Stock AXNX Stock Holding History

Royce & Associates’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-37,000	Closed	-$2.3M	–	927
2023 Q4	$2.3M	Buy	37,000 +9,000	+32%	+$503K	0.02%	627
2023 Q3	$1.57M	Hold	28,000	–	–	0.02%	678
2023 Q2	$1.41M	Sell	28,000 -30,000	-52%	-$1.6M	0.01%	710
2023 Q1	$3.16M	Sell	58,000 -27,000	-32%	-$1.58M	0.03%	593
2022 Q4	$5.32M	Sell	85,000 -4,000	-4%	-$265K	0.06%	453
2022 Q3	$6.27M	Hold	89,000	–	–	0.07%	398
2022 Q2	$5.04M	Buy	89,000 +25,000	+39%	+$1.37M	0.05%	471
2022 Q1	$4.01M	Buy	64,000 +9,000	+16%	+$485K	0.03%	602
2021 Q4	$3.08M	Buy	55,000 +8,000	+17%	+$489K	0.02%	652
2021 Q3	$3.06M	Hold	47,000	–	–	0.02%	679
2021 Q2	$2.98M	Hold	47,000	–	–	0.02%	696
2021 Q1	$2.81M	Hold	47,000	–	–	0.02%	696
2020 Q4	$2.35M	Hold	47,000	–	–	0.02%	695
2020 Q3	$2.4M	Buy	47,000 +19,000	+68%	+$793K	0.03%	646
2020 Q2	$983K	Buy	+28,000	New	+$964K	0.01%	785

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Royce & Associates's AXNX Position: Q1 2024 in Review

Royce & Associates sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 37,000 shares — an estimated $2.3M sold.

Royce & Associates first reported a position in AXNX in Q2 2020 and held it in 15 quarters. The position peaked at $6.27M in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

Royce & Associates reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Royce & Associates sold 37,000 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $2.3M.
Royce & Associates first reported a position in Axonics, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
Royce & Associates's Axonics, Inc. Common Stock position peaked at $6.27M in Q3 2022.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Royce & Associates's 13F filing for Q1 2024, filed 13 May 2024.